Advertisement

 

 

Is it a supplementary benefit to use anti-inflammatory agents in the treatment of type 2 diabetes?

Is it a supplementary benefit to use anti-inflammatory agents in the treatment of type 2 diabetes?
Author Information (click to view)

Patrice NK, Martial DJ, Bruno TP,


Patrice NK, Martial DJ, Bruno TP, (click to view)

Patrice NK, Martial DJ, Bruno TP,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

BMC research notes 2017 09 0810(1) 471 doi 10.1186/s13104-017-2785-4
Abstract
OBJECTIVE
The aim of this study was to investigate an independent correlation between high sensitivity C-reactive protein (hs-CRP) and glycated haemoglobin (HbA1c) on one side and between hs-CRP and arterial pressure in well glucose controlled type 2 diabetics on the other side.

RESULTS
The mean of HbA1c was 6.37% in this study and 70.10% of participants had an HbA1c less than 7%. A positive correlation between hs-CRP and HbA1c was found in the current study (r = 0.232; P = 0.043) and we observed a decrease of 0.79% of HbA1c of the participants when their hs-CRP was less than 1 mg/l compared to that of the participants who had hs-CRP more than 1 mg/l (5.75 ± 1.25% VS 6.54 ± 1.42% P value = 0.04 Student). No correlation was found between hs-CRP and arterial pressure in this study. These results could justify the perspective use of anti-inflammatory drugs in the management of T2D. However the presence of participants with HbA1c levels greater than 7% makes plausible the influence of confounding factors on the observed correlations.

Submit a Comment

Your email address will not be published. Required fields are marked *

9 − 7 =

[ HIDE/SHOW ]